These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 17764911)

  • 1. Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.
    Liemburg E; Sibeijn-Kuiper A; Bais L; Pijnenborg G; Knegtering H; van der Velde J; Opmeer E; de Vos A; Dlabac-De Lange J; Wunderink L; Aleman A
    Sci Rep; 2016 Feb; 6():21873. PubMed ID: 26903078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Hydrogen Proton Magnetic Resonance Technology Combined with Brain Neurometabolite Analysis in the Treatment of Cognitive Impairment Caused by Type 2 Diabetes Mellitus.
    Li S; Yin C; Zhao W; Lian X; Hong Q
    World Neurosurg; 2020 Jun; 138():654-662. PubMed ID: 31917312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study.
    Stanley JA; Vemulapalli M; Nutche J; Montrose DM; Sweeney JA; Pettegrew JW; MacMaster FP; Keshavan MS
    Schizophr Res; 2007 Jul; 93(1-3):23-32. PubMed ID: 17498928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamatergic neurotransmission in schizophrenia: A systematic review and quantitative synthesis of proton magnetic resonance spectroscopy studies across schizophrenia spectrum disorders.
    Lopes JJ; Carruthers SP; Meyer D; Dean B; Rossell SL
    Aust N Z J Psychiatry; 2024 May; ():48674241254216. PubMed ID: 38812258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of brain glutathione with magnetic Resonance spectroscopy in Schizophrenia-Spectrum disorders - A systematic review and Meta-Analysis.
    Murray AJ; Humpston CS; Wilson M; Rogers JC; Zia Ul Haq Katshu M; Liddle PF; Upthegrove R
    Brain Behav Immun; 2024 Jan; 115():3-12. PubMed ID: 37769980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.
    Yang YS; Smucny J; Zhang H; Maddock RJ
    Neuroimage Clin; 2023; 39():103461. PubMed ID: 37406595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between dorsolateral prefrontal cortex metabolic change and cognitive impairment in first-episode neuroleptic-naive schizophrenia patients.
    Huang ML; Khoh TT; Lu SJ; Pan F; Chen JK; Hu JB; Hu SH; Xu WJ; Zhou WH; Wei N; Qi HL; Shang DS; Xu Y
    Medicine (Baltimore); 2017 Jun; 96(25):e7228. PubMed ID: 28640119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of altered biochemistry in the anterior cingulate cortex of first-episode psychosis.
    Squarcina L; Stanley JA; Bellani M; Altamura CA; Brambilla P
    Epidemiol Psychiatr Sci; 2017 Apr; 26(2):122-128. PubMed ID: 28103961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Acetyl-Aspartate Level is Decreased in the Prefrontal Cortex in Subjects At-Risk for Schizophrenia.
    Mondino M; Brunelin J; Saoud M
    Front Psychiatry; 2013; 4():99. PubMed ID: 24046751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.
    Bracken BK; Rouse ED; Renshaw PF; Olson DP
    Psychiatry Res; 2013 Aug; 213(2):142-53. PubMed ID: 23769421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry.
    Spur EM; Decelle EA; Cheng LL
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40 Suppl 1(0 1):S60-71. PubMed ID: 23549758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy and thought disorder in childhood schizophrenia.
    Seese RR; O'Neill J; Hudkins M; Siddarth P; Levitt J; Tseng B; Wu KN; Caplan R
    Schizophr Res; 2011 Dec; 133(1-3):82-90. PubMed ID: 21872444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton MR spectroscopy correlates of frontal lobe function in healthy children.
    Ozturk A; Degaonkar M; Matson MA; Wells CT; Mahone EM; Horská A
    AJNR Am J Neuroradiol; 2009 Aug; 30(7):1308-14. PubMed ID: 19357380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Findings of proton magnetic resonance spectometry in the dorsolateral prefrontal cortex in adolescents with first episodes of psychosis.
    Zabala A; Sánchez-González J; Parellada M; Moreno DM; Reig S; Burdalo MT; Robles O; Desco M; Arango C
    Psychiatry Res; 2007 Oct; 156(1):33-42. PubMed ID: 17764911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study.
    Gan JL; Cheng ZX; Duan HF; Yang JM; Zhu XQ; Gao CY
    Psychiatry Res; 2014 Jul; 223(1):23-7. PubMed ID: 24831926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
    Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
    Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals.
    Wood SJ; Berger G; Velakoulis D; Phillips LJ; McGorry PD; Yung AR; Desmond P; Pantelis C
    Schizophr Bull; 2003; 29(4):831-43. PubMed ID: 14989417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration.
    Molina V; Sánchez J; Reig S; Sanz J; Benito C; Santamarta C; Pascau J; Sarramea F; Gispert JD; Misiego JM; Palomo T; Desco M
    Schizophr Res; 2005 Mar; 73(2-3):209-19. PubMed ID: 15653263
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.